99% Savings - Buy Just @1 Rs X
Caviter is a commercial drug that is prescribed in the form of Tablet. Primarily, it is used for the treatment of Tuberculosis.
The optimal dosage of Caviter is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. For detailed information on this, read through the dosage section.
Caviter also has some side effects, the most common being Rash, Erythema, Discoloration of Urine. Some other side effects of Caviter have been listed ahead. Such side effects of Caviter normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
In addition, Caviter's effect is Moderate during pregnancy and Moderate for lactating mothers. Warnings related to Caviter's effects on the liver, heart and kidney, if any, have been listed below.
Other conditions have been mentioned below in the Caviter contraindications section.
Besides this, Caviter may also have severe interaction with some medicines. Refer to the list below for further details.
You should also be aware that Caviter is not safe while driving, and is not addiction.
Caviter is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Is the use of Caviter safe for pregnant women?
Caviter can have harmful effects in pregnant women. If you experience any discomfort after using Caviter, then discontinue the use and take your doctor's advice.
Is the use of Caviter safe during breastfeeding?
Caviter can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Caviter on the Kidneys?
There can be some harmful effects on your kidneys after taking Caviter. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Caviter on the Liver?
There may be an adverse effect on the liver after taking Caviter. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of Caviter on the Heart?
You may experience side effects on your heart after taking Caviter. If this happens, then discontinue its use. Consult your medical practitioner, and do as he/she suggests.
Caviter should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Caviter unless your doctor advises you to do so -
Is this Caviter habit forming or addictive?
No, there is no any evidence that Caviter is addictive.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Caviter can make you feel drowsy.
Is it safe?
Yes, but take Caviter only as per medical advice.
Is it able to treat mental disorders?
No, Caviter cannot treat any kind of mental disorder.
Interaction between Food and Caviter
Taking Caviter with food does not harm your health.
Interaction between Alcohol and Caviter
Taking alcohol with Caviter can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Isoniazid
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 765-767
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 715-716
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 768-769
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1066-1067
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Rifadin (rifampin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 767-768
Product Description [Internet]: RIFATER® (rifampin, isoniazid and pyrazinamide USP). USFDA
Product Description [Internet]: RIFADIN®. USFDA
Product Description [Internet]: ISONIAZID. Alliance Pharmaceuticals Limited